WeMed Medical And CR Pharma Comm Carry Out Comprehensive Strategic Cooperation

As an important tool of modern medical treatment, medical devices play an extremely important role in the prevention, diagnosis, and treatment of diseases.

This Tuesday, WeMed Medical and CR Pharma Comm signed a strategic cooperation agreement in Beijing. Both sides will carry out in-depth cooperation on specific projects in strategic layout, product marketing, resource integration and etc.

cath lab

In this signing ceremony, Yang He, the Founder and CEO of WeMed Medical, and Tang Yanlin, the General Manager of CR Pharma Comm, signed a strategic cooperation agreement on behalf of both parties.

Wang Peng, the Vice General Manager of CR Pharma Comm held the ceremony. The signing ceremony was witnessed by Wang Xingkai, the Chairman of CR Pharma Comm. Zhao Lijun, the Vice Sales Director of CR Pharma Comm, and Sun Hui, the BD Director of WeMed Medical, Pang Bo, the Account Manager of WeMed Medical.

angiography machine.jpg


mobile c arm x ray machine.jpg


The CEO of WeMed Medical Yang He said, the strategic cooperation with CR Pharma Comm has great significance for the future development of WeMed Medical. The two sides will surely form a win-win situation of complementary advantages and resource sharing.

The General Manager of CR Pharma Comm Tang Yanlin said that Cooperation is more than just an expression of long-standing trust and recognition, WeMed Medical and CR Pharma Comm will conduct in-depth cooperation on specific projects.

 

About WeMed Medical

WeMed Medical was established in 2014, and has gradually grown from a small business to today's scale. The main business is to provide full solutions of Digital Subtraction Angiography System, Mobile DSA System, Mobile C arm X-ray Machine, and Interventional Robot. It is a hard technology enterprise with more than 100 patents, 80% of which are invention patents.

WeMed Medical adheres to the concept of "Innovation For Health", and perfectly creates a big family of "new domestic products" for intervention therapy. These new products and technologies are used in various fields such as cardiac intervention, neuro intervention, comprehensive intervention, peripheral vascular intervention, and tumor intervention.

 

 


You Might Also Like

Send Inquiry